Paper21994752
Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?
Nasr R and 5 others. Viruses, 2011. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects? Papers, record 21994752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21994752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Human T-lymphotropic virus 1 | Major topic |
| Leukemia-Lymphoma, Adult T-Cell | Major topic |
| Animals | |
| Antiviral Agents | |
| Drug Therapy, Combination | |
| Gene Products, tax | |
| Humans | |
| Mice | |
| Virus Replication |
Source PubMed
References111
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12613513 | Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide. | Leuk Lymphoma | 2002 | https://conductscience.org/library/papers/12613513 | PubMed |
| 2 | 9864171 | Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. | Blood | 1999 | https://conductscience.org/library/papers/9864171 | PubMed |
| 3 | 9694868 | NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9694868 | PubMed |
| 4 | 18376405 | Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. | Nat Med | 2008 | https://conductscience.org/library/papers/18376405 | PubMed |
| 5 | 19270265 | HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165. | Blood | 2009 | https://conductscience.org/library/papers/19270265 | PubMed |
| 6 | 16540180 | The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus). | Antiviral Res | 2006 | https://conductscience.org/library/papers/16540180 | PubMed |
| 7 | 1751370 | Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). | Br J Haematol | 1991 | https://conductscience.org/library/papers/1751370 | PubMed |
| 8 | 20940416 | The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. | Blood | 2011 | https://conductscience.org/library/papers/20940416 | PubMed |
| 9 | 19411628 | Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). | Blood | 2009 | https://conductscience.org/library/papers/19411628 | PubMed |
| 10 | 15522654 | New therapeutic approaches for adult T-cell leukaemia. | Lancet Oncol | 2004 | https://conductscience.org/library/papers/15522654 | PubMed |
| 11 | 10899027 | The immune response to HTLV-I. | Curr Opin Immunol | 2000 | https://conductscience.org/library/papers/10899027 | PubMed |
| 12 | 9152417 | AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro. | J Gen Virol | 1997 | https://conductscience.org/library/papers/9152417 | PubMed |
| 13 | 2871307 | HTLV-I associated myelopathy, a new clinical entity. | Lancet | 1986 | https://conductscience.org/library/papers/2871307 | PubMed |
| 14 | 20585095 | Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20585095 | PubMed |
| 15 | 21347344 | HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. | PLoS Pathog | 2011 | https://conductscience.org/library/papers/21347344 | PubMed |
| 16 | 7579327 | Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. | Blood | 1995 | https://conductscience.org/library/papers/7579327 | PubMed |
| 17 | 9808547 | Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. | Blood | 1998 | https://conductscience.org/library/papers/9808547 | PubMed |
| 18 | 15048063 | Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma. | Hematol J | 2004 | https://conductscience.org/library/papers/15048063 | PubMed |
| 19 | 7760890 | Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. | N Engl J Med | 1995 | https://conductscience.org/library/papers/7760890 | PubMed |
| 20 | 21135137 | Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. | J Exp Med | 2010 | https://conductscience.org/library/papers/21135137 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42648572 | Modeling of ex vivo immune response reveals a central role for CD8+CD25+ cells in Adult T-cell Leukemia survival: a long-term prospective cohort study. | Tumour Virus Res | 2026 | https://conductscience.org/library/papers/42648572 | PubMed |
| 37834255 | Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37834255 | PubMed |
| 37689806 | Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review. | Med Oncol | 2023 | https://conductscience.org/library/papers/37689806 | PubMed |
| 35935975 | Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia. | Front Immunol | 2022 | https://conductscience.org/library/papers/35935975 | PubMed |
| 35464257 | Molecular fusion events in carcinogenic organisms: a bioinformatics study for the detection of fused proteins between viruses, bacteria and eukaryotes. | EMBnet J | 2022 | https://conductscience.org/library/papers/35464257 | PubMed |
| 34735653 | Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities. | Curr Oncol Rep | 2021 | https://conductscience.org/library/papers/34735653 | PubMed |
| 33471856 | In vivo antagonistic role of the Human T-Cell Leukemia Virus Type 1 regulatory proteins Tax and HBZ. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/33471856 | PubMed |
| 32636814 | Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32636814 | PubMed |
| 32369988 | Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview. | Pathogens | 2020 | https://conductscience.org/library/papers/32369988 | PubMed |
| 31103249 | Molecular biology of human T cell leukemia virus. | Semin Diagn Pathol | 2020 | https://conductscience.org/library/papers/31103249 | PubMed |
| 30657736 | Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report. | J Clin Oncol | 2019 | https://conductscience.org/library/papers/30657736 | PubMed |
| 29593659 | How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy. | Front Microbiol | 2018 | https://conductscience.org/library/papers/29593659 | PubMed |
| 29296718 | Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α. | Blood Adv | 2017 | https://conductscience.org/library/papers/29296718 | PubMed |
| 27110706 | Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles. | Virology | 2016 | https://conductscience.org/library/papers/27110706 | PubMed |
| 26690203 | Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related Diseases. | Viruses | 2015 | https://conductscience.org/library/papers/26690203 | PubMed |
| 25699089 | Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer. | Infect Agent Cancer | 2014 | https://conductscience.org/library/papers/25699089 | PubMed |
| 25436765 | Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC Inhibitors. | Pathogens | 2012 | https://conductscience.org/library/papers/25436765 | PubMed |
| 24470863 | Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers. | Iran J Basic Med Sci | 2013 | https://conductscience.org/library/papers/24470863 | PubMed |
| 23962110 | The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma. | Retrovirology | 2013 | https://conductscience.org/library/papers/23962110 | PubMed |
| 23943384 | Therapeutic options for adult T-cell leukemia/lymphoma. | Curr Oncol Rep | 2013 | https://conductscience.org/library/papers/23943384 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21994752
GET https://conductscience.org/api/papers/v1/21994752/references?page=2